medicaid glp-1 Does health insurance cover drugs? Tips that may help you save on these blockbuster medications Did you know? Approximately 36%

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus and weight management

K.P., R.P., T.A., J.G.WritingReview and Editing

Pharmaceutical companies initially developed GLP-1s for diabetes treatment, but they are now widely prescribed for weight loss

Although kidney-related side effects are uncommon, staying vigilant is particularly important if you have a history of kidney issues

Currently, there are multiple lawsuits against the pharma giants for alleged inadequate or under- reporting of side effects associated with GLP-1 medications like Mounjaro and Ozempic, resulting in numerous hospitalizations and surgeries

fda.gov (Mounjaro approval press release)